• Latest Posts

Clinical Microbiomics acquires MS-Omics

More positive news announced for Verona’s COPD treatment

Way to transform Cas-9 protein into spherical nuclear acid developed

Italian study shows CRISPR/Cas9 deletion of Interleukin-30 reduces prostate cancer growth

PerkinElmer’s Horizon Discovery: the lowdown on base editing

The challenges of translating CRISPR to the clinic

ADVERTISEMENT

CRISPR/Cas9: Challenges and outlook from an investor’s perspective

More News! 14 Oct 2022

ChristianaCare spins out new gene-editing company CorriXR Therapeutics

Cytel signs agreement with two Scandinavian medicinal product companies

Beyond Biotech podcast 18: BiotechX, Cultivated Biosciences, EPFL, Faron Pharmaceuticals

Danish researchers create ‘Wikipedia of resistant bacteria’

Mablink Bioscience receives €31M series A funding for ADC pipeline 

ADVERTISEMENT